Drug Shortage Report for HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG

Last updated on 2022-03-02 History
Report ID 154792
Drug Identification Number 02125366
Brand name HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG
Common or Proper name Hydrochloride Controlled Release Capsules Capsules
Company Name PURDUE PHARMA
Market Status MARKETED
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 12MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-02-11
Actual start date 2022-02-11
Estimated end date 2022-03-04
Actual end date 2022-03-01
Shortage status Resolved
Updated date 2022-03-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-03-02 English Compare
v7 2022-03-01 French Compare
v6 2022-03-01 English Compare
v5 2022-02-25 French Compare
v4 2022-02-25 English Compare
v3 2022-02-12 English Compare
v2 2022-02-11 French Compare
v1 2022-02-11 English Compare

Showing 1 to 8 of 8